Top

Published in:

01-01-2019 | Brief Communication

Comorbidity Remission Following Intragastric Dual Balloon Placement

Authors: Luis Garcia, Sean Vajanaphanich, John M. Morton

Published in: Obesity Surgery | Issue 1/2019

Abstract

The intragastric dual balloon was FDA approved in 2015 for the treatment of obesity. The objective of this study was to report the weight loss, comorbidity remission, and biochemical improvements experienced by 28 patients following intragastric dual balloon placement at a single institution between September 2015 and June 2017. Demographic data were collected preoperatively. Anthropometric, clinical, and biochemical data were collected preoperatively and 3 and 6 months postoperatively. Two patients were lost to data follow-up. Participants experienced significant improvements in blood pressure and lipid profiles, in addition to substantial weight loss 6 months after balloon insertion. The results of this study underscore the promise of the intragastric dual balloon as an efficacious intervention for weight loss and comorbidity remission in patients with early-stage obesity.

Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9. https://doi.org/10.1038/nrgastro.2016.170.CrossRefPubMed

ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh BK, et al. Endoscopic bariatric therapies. Gastrointest Endosc. 2015;81(5):1073–86. https://doi.org/10.1016/j.gie.2015.02.023.CrossRef

Palmisano S, Silvestri M, Melchioretto B, et al. Intragastric balloon device: weight loss and satisfaction degree. Obes Surg. 2016;26(9):2131–7. https://doi.org/10.1007/s11695-016-2069-4.CrossRefPubMed

Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief. 2017;288:1–8.

Ponce J, Nguyen NT, Hutter M, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg Obes Relat Dis. 2015;11(6):1199–200. https://doi.org/10.1016/j.soard.2015.08.496.CrossRefPubMed

Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961. https://doi.org/10.1136/bmj.g3961.CrossRefPubMedPubMedCentral

Genco A, López-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23(4):515–21. https://doi.org/10.1007/s11695-012-0829-3.CrossRefPubMed

Martins Fernandes FA, Carvalho GL, Lima DL, et al. Intragastric balloon for overweight patients. JSLS. 2016;20(1):e2015.00107. https://doi.org/10.4293/JSLS.2015.00107.CrossRefPubMedPubMedCentral

Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):377–88. https://doi.org/10.1097/01.med.0000433067.01671.f5.CrossRefPubMedPubMedCentral

10.

Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288(22):2793–6. ReviewCrossRefPubMed

Title: Comorbidity Remission Following Intragastric Dual Balloon Placement
Authors: Luis Garcia
Sean Vajanaphanich
John M. Morton
Publication date: 01-01-2019
Publisher: Springer US
Published in: Obesity Surgery / Issue 1/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-018-3564-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comorbidity Remission Following Intragastric Dual Balloon Placement

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy

Letter to the Editor: Regarding The Evaluation of Screening Questionnaires for Obstructive Sleep Apnea to Identify High-Risk Obese Patients Undergoing Bariatric Surgery

Conversions After Sleeve Gastrectomy for Weight Regain: to Single and Double Anastomosis Duodenal Switch and Gastric Bypass at a Single Institution

Anastomotic Strictures After Roux-en-Y Gastric Bypass: a Cohort Study from the Scandinavian Obesity Surgery Registry

Pre- and Postbariatric Subtypes and Their Predictive Value for Health-Related Outcomes Measured 3 Years After Surgery

Urinary Incontinence and Surgery for Obesity and Weight-Related Diseases: Are There Predictors of Improvement?